Biblio Discovery — Demo Discovery Service

24 results for "Simmonds, Nicholas J."

Showing 1–20 · 0.56 seconds · RSS

  1. Journal Article Full text

    Cystic fibrosis modulator therapy can reverse cystic bronchiectasis

    Middleton, Peter G.; Simmonds, Nicholas J.

    Respirol Case Rep · 2023 · English · PubMed Central

    Bronchiectasis is often considered progressive and irreversible, so cases of regression or reversal are an important step in understanding the underlying pathophysiological mechanisms. Cystic fibrosis, (CF) caused by pathogenic variants in the cystic fibrosis transmembrane conductance regulator…

  2. Journal Article Full text

    Pulmonary Exacerbations in Adults With Cystic Fibrosis

    Stanford, Gemma E.; Dave, Kavita; Simmonds, Nicholas J.

    Chest · 2020 · English · PubMed Central

    Pulmonary exacerbations (PExs) are significant life events in people with cystic fibrosis (CF), associated with declining lung function, reduced quality of life, hospitalizations, and decreased survival. The adult CF population is increasing worldwide, with many patients surviving prolonged periods…

  3. Journal Article Full text

    Beyond Cystic Fibrosis: Recognising Shwachman‐Diamond Syndrome in the Respiratory Clinic

    Yang, Freda; Weitnauer, Ladina; Felton, Imogen et al.

    Respirol Case Rep · 2025 · English · PubMed Central

    Cystic fibrosis (CF) and Shwachman‐Diamond Syndrome (SDS) share overlapping features, including recurrent respiratory infections and pancreatic insufficiency, which can complicate diagnosis. We report a case of a six‐year‐old girl who presented with productive cough, steatorrhea and recurrent…

  4. Journal Article Full text

    The changing demography of the cystic fibrosis population: forecasting future numbers of adults in the UK

    Keogh, Ruth H.; Tanner, Kamaryn; Simmonds, Nicholas J. et al.

    Sci Rep · 2020 · English · PubMed Central

    Improvements in management of cystic fibrosis (CF) through specialist centres in the UK have been associated with a step-change in life expectancy. With increasing numbers of adult patients there is a need to review health care provision to ensure it is sufficient to meet future needs. We used UK…

  5. Journal Article Full text

    A woman with cystic fibrosis, severe hypoxaemia, an atrial thrombus and a patent foramen ovale: a case report

    Simmonds Nicholas J; Wyatt Hilary; Patel Raj et al.

    Journal of Medical Case Reports, Vol. 3 No. 1 · 2009 · English · DOAJ Scopus

    Abstract Introduction Cystic fibrosis is usually associated with chronic pulmonary sepsis and frequent infective exacerbations. We report a very unusual cause of severe hypoxaemia in a woman with cystic fibrosis caused by thrombus formation in the right atrium. Case presentation A 21-year-old…

    Also available at: PubMed Central

  6. Journal Article Full text

    Is daily physical activity affected by dynamic hyperinflation in adults with cystic fibrosis?

    Savi, Daniela; Di Paolo, Marcello; Simmonds, Nicholas J. et al.

    BMC Pulm Med · 2018 · English · PubMed Central

    BACKGROUND: The aim of this study was to investigate the relationship between dynamic hyperinflation and daily physical activity (DPA) in adults with cystic fibrosis (CF). METHODS: Thirty-four clinically stable CF were studied. All patients undertook incremental cardiopulmonary exercise testing…

  7. Journal Article Full text

    Assessing the health risk of living near composting facilities on lung health, fungal and bacterial disease in cystic fibrosis: a UK CF Registry study

    Khan, Muhammad Saleem; Douglas, Philippa; Hansell, Anna L. et al.

    Environ Health · 2022 · English · PubMed Central

    AIM: To explore the health risk of living near permitted composting sites (PCSs) on disease severity in children and adults with cystic fibrosis (CF) across the UK. METHODS: A semi-individual cross-sectional study was used to examine the risk of disease severity in people with CF (pwCF) within and…

  8. Journal Article Full text

    Mediation of the total effect of cystic fibrosis‐related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study

    Tanner, Kamaryn T.; Daniel, Rhian M.; Bilton, Diana et al.

    Diabet Med · 2022 · English · PubMed Central

    AIM: To investigate whether the effect of cystic fibrosis‐related diabetes (CFRD) on the composite outcome of mortality or transplant could act through lung function, pulmonary exacerbations and/or nutritional status. METHODS: A retrospective cohort of adult cystic fibrosis (CF) patients who had…

  9. Journal Article Full text

    Yoga Outcomes Get Assessed in Cystic Fibrosis (YOGA-CF): protocol of a multicentre interventional randomised controlled clinical trial—investigating effects of a 12-week yoga intervention for adults with cystic fibrosis

    Stanford, Gemma E; Scarborough, P; Charman, Susan C et al.

    BMJ Open Respir Res · 2026 · English · PubMed Central

    INTRODUCTION: Yoga is an emerging exercise choice for people with cystic fibrosis (CF), but evidence of its effect in this population is scarce, with a recent systematic review advocating for further research. Yoga Outcomes Get Assessed in CF (YOGA-CF) is a real-world multicentre randomised…

  10. Journal Article Full text

    Investigating outcome measures for assessing airway clearance techniques in adults with cystic fibrosis: protocol of a single-centre randomised controlled crossover trial

    Stanford, Gemma; Davies, Jane C; Usmani, Omar et al.

    BMJ Open Respir Res · 2020 · English · PubMed Central

    INTRODUCTION: Airway clearance techniques (ACTs) are a gold standard of cystic fibrosis management; however, the majority of research evidence for their efficacy is of low standard; often attributed to the lack of sensitivity from outcome measures (OMs) used historically. This randomised controlled…

  11. Journal Article Full text

    Burkholderia cepacia complex and limited cutaneous vasculitis in patients with cystic fibrosis: a case series

    Kayria, Muttardi; Chris, Orchard; Dhasmana, Devesh J et al.

    JRSM Open · 2017 · English · PubMed Central

    There is a high association of reactive skin presentations, mainly limited cutaneous vasculitis in patients with cystic fibrosis and Burkholderia cepcia complex chronic infection. This may be due to raised levels of circulating inflammatory mediators.

  12. Journal Article Full text

    Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review

    Stanford, Gemma E.; Jones, Mandy; Charman, Susan C. et al.

    Ther Adv Respir Dis · 2022 · English · PubMed Central

    BACKGROUND: Airway clearance techniques (ACTs) are integral to cystic fibrosis (CF) management. However, there is no consensus as to which outcome measures (OMs) are best for assessing ACT efficacy. OBJECTIVES: To summarise OMs that have been assessed for their clinimetric properties (including…

  13. Journal Article Full text

    Treatment Preference Among People With Cystic Fibrosis

    Cameron, Rory A.; Office, Daniel; Matthews, Jessie et al.

    Chest · 2022 · English · PubMed Central

    BACKGROUND: There is a growing consensus that the perspective of the patient should be considered in the evaluation of novel interventions. RESEARCH QUESTION: What treatment outcomes matter to people with cystic fibrosis (CF), and what trade-offs would they make to realize these outcomes? STUDY…

  14. Journal Article Full text

    Increased NFAT and NFκB signalling contribute to the hyperinflammatory phenotype in response to Aspergillus fumigatus in a mouse model of cystic fibrosis

    Bercusson, Amelia; Williams, Thomas J.; Simmonds, Nicholas J. et al.

    PLoS Pathog · 2025 · English · PubMed Central

    Aspergillus fumigatus (Af) is a major mould pathogen found ubiquitously in the air. It commonly infects the airways of people with cystic fibrosis (CF) leading to Aspergillus bronchitis or allergic bronchopulmonary aspergillosis. Resident alveolar macrophages and recruited neutrophils are important…

  15. Journal Article Full text

    New strategies of physical activity assessment in cystic fibrosis: a pilot study

    Savi, Daniela; Graziano, Luigi; Giordani, Barbara et al.

    BMC Pulm Med · 2020 · English · PubMed Central

    BACKGROUND: Regular physical activity (PA) is a valued part of cystic fibrosis (CF) care. Although the accelerometer, SenseWear Armband (SWA), accurately measures habitual PA in CF, it is mostly used for research purposes. For the first time, we analyzed different methods of measuring PA in daily…

  16. Journal Article Full text

    The fungal airway microbiome in cystic fibrosis and non-cystic fibrosis bronchiectasis

    Cuthbertson, Leah; Felton, Imogen; James, Phillip et al.

    J Cyst Fibros · 2021 · English · PubMed Central

    BACKGROUND: The prevalence of fungal disease in cystic fibrosis (CF) and non-CF bronchiectasis is increasing and the clinical spectrum is widening. Poor sensitivity and a lack of standard diagnostic criteria renders interpretation of culture results challenging. In order to develop effective…

  17. Journal Article Full text

    Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures

    van Koningsbruggen-Rietschel, Silke; Dunlevy, Fiona; Bulteel, Veerle et al.

    Trials · 2021 · English · PubMed Central

    The SARS-CoV-2 pandemic has disrupted clinical trials worldwide. The European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN) has tracked clinical trial disruption by surveying its 58 trial sites across 17 European countries and collated information on measures to mitigate the impact of…

  18. Journal Article Full text

    Improving ototoxicity monitoring in patients receiving aminoglycosides using a novel digital approach: a quality improvement project

    Cheong, Jamie; Boreland, Shereen; Shattock, Elaine et al.

    BMJ Open Qual · 2025 · English · PubMed Central

    Aminoglycoside antibiotics cause ototoxicity for which baseline audiometric testing is recommended but often not done. Barriers to successful implementation include limited availability of sound-booths and audiologists. An ototoxicity monitoring programme (OMP) was implemented using tablet-based…

  19. Journal Article Full text

    Spirometry thresholds for clinical trial eligibility: time for urgent re-evaluation

    Bokobza, Idan; Le Sayec, Melanie; Bossley, Cara et al.

    Thorax · 2025 · English · PubMed Central

    A common eligibility criterion in respiratory clinical trials is a per cent-predicted forced expiratory volume in 1 second (ppFEV(1)) between 40% and 90%, using the ethnicity-dependent Global Lung Function Initiative (GLI)-2012 spirometry reference equations. International societies now endorse the…